Number of items: 9.
Articles
Carberry, J. et al.
(2024)
Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI).
European Journal of Heart Failure,
(doi: 10.1002/ejhf.3560)
(Early Online Publication)
Ang, D. T.Y. et al.
(2024)
Coronary microvascular function and atherosclerotic plaque burden in ischaemia and no obstructive coronary arteries: a secondary analysis of the CorMicA trial.
Heart,
(doi: 10.1136/heartjnl-2024-324677)
(PMID:39603791)
(Early Online Publication)
Carberry, J. et al.
(2024)
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design.
ESC Heart Failure, 11(4),
pp. 2001-2012.
(doi: 10.1002/ehf2.14830)
(PMID:38715187)
(PMCID:PMC11287338)
Ramses, R., Kennedy, S. , Good, R., Oldroyd, K. G. and Mcginty, S.
(2024)
Performance of drug-coated balloons in coronary and below-the-knee arteries: anatomical, physiological and pathological considerations.
Vascular Pharmacology, 155,
107366.
(doi: 10.1016/j.vph.2024.107366)
(PMID:38479462)
Bradley, C. P. et al.
(2023)
The coronary microvascular angina cardiovascular magnetic resonance imaging trial: rationale and design.
American Heart Journal, 265,
pp. 213-224.
(doi: 10.1016/j.ahj.2023.08.067)
(PMID:37657593)
Ohashi, H. et al.
(2023)
Fractional flow reserve guided stent optimisation in focal and diffuse coronary artery disease.
Diagnostics, 13(15),
2612.
(doi: 10.3390/diagnostics13152612)
(PMID:37568975)
(PMCID:PMC10417445)
Collison, D. et al.
(2023)
Angina after percutaneous coronary intervention: patient and procedural predictors.
Circulation: Cardiovascular Interventions, 16(4),
e012511.
(doi: 10.1161/CIRCINTERVENTIONS.122.012511)
(PMID:36974680)
(PMCID:PMC10101135)
Ford, T. J. et al.
(2022)
Coronary artery perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study.
Journal of the American Heart Association, 11(19),
e024492.
(doi: 10.1161/JAHA.121.024492)
(PMID:36129052)
(PMCID:PMC9673697)
Conference or Workshop Item
Sykes, R. et al.
(2023)
Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: A registry-based, stratified-medicine, randomised, controlled trial.
British Society of Cardiovascular Magnetic Resonance (BSCMR) 17th Annual Congress, Liverpool, UK, 11-12 Oct 2022.
(doi: 10.1136/heartjnl-2022-BSCMR.26)
This list was generated on Fri Feb 21 08:53:05 2025 GMT.
